3rd Quarter - Report — AMEDISYS, INC. for AMEDISYS, INC. (2024)

Firm

AMEDISYS, INC.

Client

AMEDISYS, INC.

Income

—

Expenses

$340,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to home health and hospice payment policies and funding (FY 2025 Hospice Proposed Rule and CY 2025 Home Health Proposed Rule), program integrity matters and quality metrics, continuation of hospital-at-home; Hospice Special Focus Program included in the CY 2024 Home Health Proposed and Final Rules; Issues related to healthcare workforce matters; Preserving Access to Home Health Act of 2023 (S. 2137/H.R. 5159); Telehealth Modernization Act (H.R. 7623); Hospital Inpatient Services Modernization Act (S. 4350); Hospice CARE Act of 2024 (H.R. 9803)

Lobbyist	Covered position, as disclosed
SCOTT M. LEVY	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); White House Office

Bills named: H.R. 5159 (118th), H.R. 7623 (118th), H.R. 9803 (118th), S. 4350 (118th), S. 2137 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.